navigation: true

Recapitulation of Living Tissue Complexity

Innovative and Unique Bioink Formulations

Novel 3D Bioprinting Approach

 

Bioprinted Tissues-on-Demand

 

Morphodyne, a spinoff from École Polytechnique Fédérale de Lausanne (EPFL) in Switzerland, is developing 3D tissue and disease models based on its unique 3D bioprinting technology platform. Morphodyne combines proprietary bioink formulations with an innovative multimaterial printing approach to mimic tissue complexity. We aim to provide drug discovery and development pipelines with new assays able to better measure candidate efficacy and/or toxicity.


2D Cell-Based
Assays

Non-physiological conditions


3D Cell-Based
Assays

Lack of tissue complexity


Bioprinted Tissue Models

Recapitulation of tissue complexity


In Vivo
Studies

Stringent ethical issues


     Home | Contact

     © | Morphodyne SA - All rights reserved